MEDICINAL cannabis distributor Leafio has entered into an agreement to distribute Canadian company Organigram Global's Boxhot and Edison brands to Australian patients.
Organigram operates the world's largest indoor cannabis cultivation facility, with product development capabilities across dried flower, oils, and next-generation cannabis formats such as vapes and pastilles.
The company also has an established track record of supplying international cannabis markets with high-quality medicinal cannabis products and brings significant research and development expertise to the partnership
The agreement aims to broaden Leafio's extensive product offering to the 4,000 pharmacies it supplies, as the sector continues to mature in 2026.
This distribution agreement for Organigram brands represents an important step in expanding Leafio's medicinal cannabis portfolio," said Leafio GM Nicole Le Maistre.
"Organigram's manufacturing capabilities and regulatory experience align strongly with our focus on compliance, reliability, and patient access.
"We look forward to working closely with Organigram, leveraging strong synergies for collaboration as the Australian market continues to mature."
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Feb 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Feb 26
